Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Advair Pediatric Once-Daily

ClinicalTrials.gov ID: NCT00920959

Public ClinicalTrials.gov record NCT00920959. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 3:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Stratified, Randomized, Double-blind, Placebo-controlled, Parallel-group, 12 Week Trial Evaluating the Safety and Efficacy of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg Once Daily Versus Fluticasone Propionate DISKUS 100mcg Once Daily and Placebo in Symptomatic Pediatric Subjects (4-11 Years) With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate if once-daily dosing of ADVAIR 100/50 once-daily has superior efficacy and comparable safety compared with FP 100mcg once-daily in pediatric subjects 4 to 11 years of age with asthma.

Study identification

NCT ID
NCT00920959
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
908 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
4 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2001 (Type not available)
Primary completion
Jan 2004 (Actual)
Completion
Jan 2004 (Actual)
Last update posted
Sep 15, 2016

2001 – 2004

United States locations

U.S. sites
141
U.S. states
35
U.S. cities
121
Facility City State ZIP Site status
GSK Investigational Site Ozark Alabama 36360 —
GSK Investigational Site Tucson Arizona 85716 —
GSK Investigational Site Tucson Arizona 85746 —
GSK Investigational Site Little Rock Arkansas 72205 —
GSK Investigational Site Beverly Hills California 90212 —
GSK Investigational Site Crescent City California 95531 —
GSK Investigational Site Dinuba California 93618 —
GSK Investigational Site Fresno California 93720 —
GSK Investigational Site Huntington Beach California 92647 —
GSK Investigational Site La Jolla California 92093 —
GSK Investigational Site Long Beach California 90806 —
GSK Investigational Site Mission Viejo California 92691 —
GSK Investigational Site Newport Beach California 92660 —
GSK Investigational Site Orange California 92868 —
GSK Investigational Site Palmdale California 93551 —
GSK Investigational Site Panorama City California 91402 —
GSK Investigational Site Paramount California 90723 —
GSK Investigational Site Riverside California 92506 —
GSK Investigational Site Rolling Hills Estates California 90274 —
GSK Investigational Site San Diego California 92120 —
GSK Investigational Site San Francisco California 94102 —
GSK Investigational Site San Jose California 95117 —
GSK Investigational Site Sherman Oaks California 91403 —
GSK Investigational Site Vista California 92083 —
GSK Investigational Site Vista California 92084 —
GSK Investigational Site Walnut Creek California 94598 —
GSK Investigational Site Centennial Colorado 80112 —
GSK Investigational Site Colorado Springs Colorado 80907 —
GSK Investigational Site Denver Colorado 80206 —
GSK Investigational Site Denver Colorado 80218 —
GSK Investigational Site Denver Colorado 80230 —
GSK Investigational Site Pueblo Colorado 81008 —
GSK Investigational Site Altamonte Springs Florida 32701 —
GSK Investigational Site Hialeah Florida 33013 —
GSK Investigational Site Jacksonville Florida 32216 —
GSK Investigational Site Orlando Florida 32801 —
GSK Investigational Site Orlando Florida 32806 —
GSK Investigational Site Sarasota Florida 34233 —
GSK Investigational Site St. Petersburg Florida 33710 —
GSK Investigational Site Tallahassee Florida 32308 —
GSK Investigational Site Tampa Florida 33613 —
GSK Investigational Site Atlanta Georgia 30309-7520 —
GSK Investigational Site Augusta Georgia 30901 —
GSK Investigational Site Barnesville Georgia 30204 —
GSK Investigational Site Martinez Georgia 30907 —
GSK Investigational Site Savannah Georgia 31406 —
GSK Investigational Site Chicago Illinois 60612 —
GSK Investigational Site Glenview Illinois 60025 —
GSK Investigational Site Hoffman Estates Illinois 60195 —
GSK Investigational Site Park Ridge Illinois 60068 —
GSK Investigational Site Indianapolis Indiana 46208 —
GSK Investigational Site South Bend Indiana 46617 —
GSK Investigational Site Lawrence Kansas 66047 —
GSK Investigational Site Louisville Kentucky 40222 —
GSK Investigational Site Murray Kentucky 42071 —
GSK Investigational Site Covington Louisiana 70433 —
GSK Investigational Site Metairie Louisiana 70001 —
GSK Investigational Site Metairie Louisiana 70006 —
GSK Investigational Site Shreveport Louisiana 71104 —
GSK Investigational Site Sunset Louisiana 70584 —
GSK Investigational Site Newton Massachusetts 02462 —
GSK Investigational Site North Dartmouth Massachusetts 02747 —
GSK Investigational Site Taunton Massachusetts 02780 —
GSK Investigational Site West Quincy Massachusetts 02169 —
GSK Investigational Site Detroit Michigan 48202 —
GSK Investigational Site Minneapolis Minnesota 55416 —
GSK Investigational Site Columbia Missouri 65212 —
GSK Investigational Site Kansas City Missouri 64108 —
GSK Investigational Site St Louis Missouri 63108 —
GSK Investigational Site St Louis Missouri 63139 —
GSK Investigational Site St Louis Missouri 63141 —
GSK Investigational Site Missoula Montana 59804 —
GSK Investigational Site Omaha Nebraska 68130 —
GSK Investigational Site Omaha Nebraska 68134 —
GSK Investigational Site Papillion Nebraska 68046 —
GSK Investigational Site Berlin New Jersey 08009 —
GSK Investigational Site Brick New Jersey 8724 —
GSK Investigational Site East Orange New Jersey 7017 —
GSK Investigational Site Ocean City New Jersey 07712 —
GSK Investigational Site Verona New Jersey 7044 —
GSK Investigational Site Albuquerque New Mexico 87131 —
GSK Investigational Site Buffalo New York 14222 —
GSK Investigational Site Liverpool New York 13088 —
GSK Investigational Site New Hyde Park New York 11042 —
GSK Investigational Site Rockville Centre New York 11570 —
GSK Investigational Site Vestal New York 13850 —
GSK Investigational Site Asheville North Carolina 28801 —
GSK Investigational Site Charlotte North Carolina 28204 —
GSK Investigational Site Durham North Carolina 27704 —
GSK Investigational Site Elizabeth City North Carolina 27909 —
GSK Investigational Site Winston-Salem North Carolina 27103 —
GSK Investigational Site Canton Ohio 44718 —
GSK Investigational Site Cincinnati Ohio 45231 —
GSK Investigational Site Cleveland Ohio 44106 —
GSK Investigational Site Oklahoma City Oklahoma 73112 —
GSK Investigational Site Oklahoma City Oklahoma 73120 —
GSK Investigational Site Bend Oregon 97701 —
GSK Investigational Site Medford Oregon 97504 —
GSK Investigational Site Portland Oregon 97213 —
GSK Investigational Site Portland Oregon 97223 —
GSK Investigational Site Altoona Pennsylvania 16601 —
GSK Investigational Site Blue Belle Pennsylvania 19422 —
GSK Investigational Site Harrisburg Pennsylvania 17110 —
GSK Investigational Site Lewisburg Pennsylvania 17837 —
GSK Investigational Site Philadelphia Pennsylvania 19135 —
GSK Investigational Site Pittsburgh Pennsylvania 15202 —
GSK Investigational Site Pittsburgh Pennsylvania 15241 —
GSK Investigational Site Upland Pennsylvania 19013 —
GSK Investigational Site Lincoln Rhode Island 02865-4208 —
GSK Investigational Site Charleston South Carolina 29407 —
GSK Investigational Site Greenville South Carolina 29607 —
GSK Investigational Site Mt. Pleasant South Carolina 29464 —
GSK Investigational Site Spartanburg South Carolina 29303 —
GSK Investigational Site Knoxville Tennessee 37916 —
GSK Investigational Site Knoxville Tennessee 37917 —
GSK Investigational Site Knoxville Tennessee 37922 —
GSK Investigational Site Austin Texas 78749 —
GSK Investigational Site Dallas Texas 75230 —
GSK Investigational Site El Paso Texas 79902 —
GSK Investigational Site El Paso Texas 79925 —
GSK Investigational Site Galveston Texas 77555-0188 —
GSK Investigational Site Houston Texas 77054 —
GSK Investigational Site Houston Texas 77065 —
GSK Investigational Site Houston Texas 77074 —
GSK Investigational Site Lake Jackson Texas 77566 —
GSK Investigational Site New Braunfels Texas 78130 —
GSK Investigational Site Plano Texas 75093 —
GSK Investigational Site San Antonio Texas 78205 —
GSK Investigational Site San Antonio Texas 78207 —
GSK Investigational Site San Antonio Texas 78233 —
GSK Investigational Site Layton Utah 84041 —
GSK Investigational Site Murray Utah 84107 —
GSK Investigational Site Burke Virginia 22015 —
GSK Investigational Site Norfolk Virginia 23510 —
GSK Investigational Site Richmond Virginia 23229 —
GSK Investigational Site Richmond Virginia 23298 —
GSK Investigational Site Edmonds Washington 98026 —
GSK Investigational Site Tacoma Washington 98405 —
GSK Investigational Site Charleston West Virginia 25301 —
GSK Investigational Site Greenfield Wisconsin 53228 —
GSK Investigational Site La Crosse Wisconsin 54601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00920959, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2016 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00920959 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →